This study aimed to combine the biomarkers of HF (BNP and sST2) and renal injury (NGAL and cystatin C) at presentation in the prediction of AKI in STEMI patients undergoing primary percutaneous coronary intervention (PCI). This evidence concerns the gene LCN2 and hydrops fetalis.